According to a new Belgian study, llama and camel blood have the necessary antibodies that can neutralize the virus.
Scientists from the Vlaams Institute for Biotechnology in Ghent have stated that particles in llama blood may serve as useful therapeutics during coronavirus outbreaks.
The study added that the feasibility of using llama antibodies merits further investigation.
Initially, these antibodies were used in HIV research but they have also proved effective against other viruses as well, including Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS).
Hepatitis B virus (HBV) imposes an important burden to human health worldwide. Approximately 350 to 400 million persons are chronically infected. Among these, 15% to 40% will develop cirrhosis, liver failure, and/or hepatocellular carcinoma, resulting in 500,000 to 700,000 deaths each year
The astonishing power of antibodies stored in the blood of camelids meaning camels, llamas, and alpacas was first discovered in 1989 by Brussels University.
The minuscule size of these antibodies helps them attack microscopic viruses far more efficiently known as nanobody technology.
Experts in South Korea have found that ferrets could be a useful tool to evaluate the efficacy of antiviral treatment and preventive vaccines as they acted similarly to human
Research has found Syrian hamsters reacting to COVID-19 which closely resembles the manifestations of upper and lower respiratory tract infection in humans.
This was published in the Science magazine and found eight hamsters lost weight, became lethargic, and developed ruffled fur, a hunched posture, and rapid breathing when exposed to the virus.